For more information on Parkinson’s research please visit the EPDA website.
Researchers develop light-activated Parkinson’s drug
News
Author: Simge Eva DoganPublished: 18 July 2018
Prep:
Cook:
Serves:

A new light-activated drug for treating Parkinson’s has been developed by a research team led by the University of Barcelona, Spain.
The drug – named MRS7145 – is placed within a brain implant and then activated by shining a light on it.
The effect of the newly developed drug was tested on live mice to see if it could improve their motor function. The results – published in ‘Journal of Controlled Release’ – showed that MRS7145 reduced tremors and seizures and improved the mice’s ability to walk.
Professor Francisco Ciruela, researcher at the Faculty of Medicine and Health Sciences of the University of Barcelona, Spain, said he envisaged the drug being administered by smart phones, with “the doctor (controlling) in a precise manner the release of the most efficient dose of the active drug in the place of action”.
Last Month
Next Month
Share this story
Related articles

sponsored article
Advances
5 things you might not know about DBS
Diving deeper into deep brain stimulation with Dr Lennart Stieglitz
READ MORE
Advances
Could an Apple smart watch track your Parkinson’s disease symptoms?
Researchers hope the innovation could be used to support clinicians
READ MORE
In my country
Supporting 100,000 Australians with Parkinson’s
We spoke to the CEO of Parkinson’s Australia
READ MORE
Comments